EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 -3.785
March 31, 2026 -5.59
December 31, 2025 -3.754
September 30, 2025 -3.490
June 30, 2025 -3.464
March 31, 2025 -3.135
December 31, 2024 -4.638
September 30, 2024 -5.034
June 30, 2024 -5.269
March 31, 2024 -5.877
December 31, 2023 -6.027
September 30, 2023 -5.982
June 30, 2023 -6.319
March 31, 2023 -6.246
December 31, 2022 -6.498
September 30, 2022 1.556
June 30, 2022 1.931
March 31, 2022 2.157
December 31, 2021 2.745
September 30, 2021 -5.161
June 30, 2021 -3.565
March 31, 2021 -3.115
December 31, 2020 -2.995
September 30, 2020 -2.476
Date Value
June 30, 2020 -3.642
March 31, 2020 -2.775
December 31, 2019 -2.582
September 30, 2019 -1.755
June 30, 2019 -1.380
March 31, 2019 -1.041
December 31, 2018 2.886
September 30, 2018 2.265
June 30, 2018 2.16
March 31, 2018 1.39
December 31, 2017 -2.47
September 30, 2017 -2.701
June 30, 2017 -2.716
March 31, 2017 -2.794
December 31, 2016 -2.383
September 30, 2016 -1.842
June 30, 2016 -2.681
March 31, 2016 -2.479
December 31, 2015 -2.165
September 30, 2015 -1.957
June 30, 2015 -0.4325
March 31, 2015 -0.0869
March 31, 2014 0.0081

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
AbbVie, Inc. 3.537
United Therapeutics Corp. 27.96
Ardelyx, Inc. -0.2261
Biomea Fusion, Inc. -0.4971
RenovoRx, Inc. -0.314